查看購物車
  • Simplified Chinese
  • English
  • Japanese
  • Korean
封面
市場調查報告書
商品編碼
1519474

2024-2032 年按產品和服務、樣本類型、最終用戶和地區分類的藥物篩選市場報告

Drug Screening Market Report by Product and Service, Sample Type, End User, and Region 2024-2032
出版日期: | 出版商: IMARC | 英文 149 Pages | 商品交期: 2-3個工作天內

價格

IMARC Group年全球藥物篩選市場規模達64億美元。毒販和當地毒販數量的不斷增加、藥物濫用案件的增加以及虛擬貨幣使用的增加是推動藥物篩檢市場成長的一些關鍵因素。

藥物篩選市場分析：

主要市場促進因素：對藥物篩選的需求不斷增加，因為它是準確的並能提供自發性的結果，這主要推動了市場的成長。此外，世界各地不斷增加的藥物濫用案件也推動了全球市場的發展。

主要市場趨勢：將自動化、人工智慧 (AI) 和分子診斷等先進技術與藥物篩選測試相結合，以簡化工作流程、減少人為錯誤並增強測試，這是重要的關鍵趨勢之一，支持了市場生長。

競爭格局：一些領先的藥物篩選市場公司包括 Abbott Laboratories、Alfa Scientific Designs Inc.、Bio-Rad Laboratories Inc.、Dragerwerk AG & Co. KGaA、Laboratory Corporation of America Holdings、Lifeloc Technologies Inc.、Omega Laboratories Inc.。 、OraSure Technologies Inc.、Psychemedics Corporation、Quest Diagnostics Incorporated、Siemens AG 和Thermo Fisher Scientific Inc. 等。

地理趨勢：根據報告，北美是最大的藥物篩選市場。該地區的成長可歸因於藥物濫用案件的不斷升級、毒販數量的增加以及處方藥黑市的增加。

挑戰與機會：藥物篩選市場面臨著與開發準確可靠的測試、克服誤報和陰性以及解決有關樣本收集和測試程序的隱私和道德問題相關的障礙。機會在於整合人工智慧和機器學習等先進技術進行資料分析，以及開發攜帶式和即時檢測設備以實現方便、快速的篩選應用。

藥物篩選市場趨勢：

毒品和酒精消費量增加

藥物消費的增加導致對藥物篩選產品的需求增加。例如，根據 2023 年歐洲毒品報告，據報導歐盟約有 8,340 萬成年人 (29%) 至少使用過一次非法藥物。大麻是歐洲消費的主要非法藥物，根據國家調查，預計 2022 年將有 8% 的歐洲成年人使用大麻。因此，大量人口消費藥物，這影響了個人的生活，並可能增加對藥物篩選的需求，從而推高藥物篩選市場的近期價格。此外，藥物和酒精的使用不斷增加以及治療需求預計將增加對醫院藥物篩檢的需求。例如，根據政府發布的國家統計數據。英國，2023 年 12 月、2022 年 4 月至 2023 年 3 月期間，約 290,635 名成年人獲得了有關藥物使用問題的支持。與前一年相比，這一數字略有上升，約 289,215 人。此外，同一消息來源稱，2022 年至 2023 年接受治療的成年人數量約為137,749 人，高於前兩年的 130,490 人和 133,704 人。藥物濫用人數的大幅增加預計將推動藥物篩檢市場需求。

政府規章

多項法律和法規要求在各個領域進行藥物和酒精檢測，這些法律的實施正在增加對藥物篩檢產品和設備的需求。例如，2022 年 11 月，聯邦汽車運輸安全管理局 (FMCSA) 發布了更新，概述了藥物和酒精測試要求。這些規定明確了接受檢測的個人、檢測頻率以及觸發檢測的情況。此外，這些法規還透過限制雇主和服務代理使用和揭露敏感的藥物和酒精檢測資訊來保護員工的隱私。除了監管框架外，各國政府當局也在採取措施幫助嚴重成癮者和吸毒者，這進一步推動了藥物篩檢市場佔有率的成長。例如，Nasha Mukt Bharat Abhiyaan 是印度政府的一項計劃，旨在透過各種活動（例如提高認知計劃）接觸群眾並傳播對藥物濫用的認知。同樣，加拿大政府當局也在投資反毒品戰略項目，幫助吸毒成癮者擺脫藥物濫用。例如，加拿大艾伯塔省卡加利約翰霍華德協會致力於幫助13至24歲時因毒癮而面臨輟學風險的青少年。

測試技術的進步

快速檢測試劑盒、實驗室檢測和即時護理設備等藥物篩選技術的不斷進步，透過提供更快、更準確和更具成本效益的篩選解決方案，進一步推動了市場成長。此外，藥物篩選技術的不斷改進提高了準確性和可靠性，減少了假陽性或假陰性的可能性，確保了測試結果的可信度並最大限度地減少了驗證性測試的需要，從而簡化了篩選過程並降低了成本。例如，2024 年 2 月，Mobile Health 在紐約診所推出了一項新的快速藥物檢測服務，供雇主輕鬆篩選和僱用候選人。同樣，2023 年10 月，ProciseDx Inc. 獲得FDA 重新批准對阿達木單抗（Humira 和生物學名藥Amgevita）和英夫利西單抗（Remicade 和生物學名藥Inflectra 和Renflexis）進行治療藥物監測(TDM)測試。這些檢測方法稱為 Procise ADL 和 Procise IFX，用於對服用阿達木單抗 (ADL) 和英夫利西單抗 (IFX) 的發炎性腸道疾病 (IBD) 患者進行定量。預計新藥物測試和儀器的批准增加將在未來幾年推動藥物篩選市場的收入。

目錄

第1章：前言

第 2 章：範圍與方法

  • 研究目的
  • 利害關係人
  • 資料來源
    • 主要資源
    • 二手資料
  • 市場預測
    • 自下而上的方法
    • 自上而下的方法
  • 預測方法

第 3 章：執行摘要

第 4 章：簡介

  • 概述
  • 主要行業趨勢

第 5 章：全球藥物篩選市場

  • 市場概況
  • 市場業績
  • COVID-19 的影響
  • 市場預測

第 6 章：市場區隔：依產品與服務

  • 裝置
    • 市場走向
    • 關鍵環節
      • 免疫分析儀
      • 色譜儀器
      • 呼吸分析儀
    • 市場預測
  • 快速檢測設備
    • 市場走向
    • 關鍵環節
      • 尿液檢測設備
      • 口腔液測試裝置
    • 市場預測
  • 耗材
    • 市場走向
    • 關鍵環節
      • 檢測試劑盒
      • 樣品收集杯
      • 校準器和控制裝置
      • 其他
    • 市場預測
  • 實驗室服務
    • 市場走向
    • 市場預測

第 7 章：市場區隔：依樣本類型

  • 尿液樣本
    • 市場走向
    • 市場預測
  • 呼吸樣本
    • 市場走向
    • 市場預測
  • 口腔液樣本
    • 市場走向
    • 市場預測
  • 頭髮樣本
    • 市場走向
    • 市場預測
  • 其他
    • 市場走向
    • 市場預測

第 8 章：市場區隔：依最終用戶

  • 醫院
    • 市場走向
    • 市場預測
  • 藥物檢測實驗室
    • 市場走向
    • 市場預測
  • 工作場所
    • 市場走向
    • 市場預測
  • 戒毒治療中心
    • 市場走向
    • 市場預測
  • 疼痛管理中心
    • 市場走向
    • 市場預測
  • 個人用戶
    • 市場走向
    • 市場預測
  • 刑事司法系統和執法機構
    • 市場走向
    • 市場預測

第 9 章：市場區隔：按地區

  • 北美洲
    • 美國
    • 加拿大
  • 亞太
    • 中國
    • 日本
    • 印度
    • 韓國
    • 澳洲
    • 印尼
    • 其他
  • 歐洲
    • 德國
    • 法國
    • 英國
    • 義大利
    • 西班牙
    • 俄羅斯
    • 其他
  • 拉丁美洲
    • 巴西
    • 墨西哥
    • 其他
  • 中東和非洲
    • 市場走向
    • 市場細分：按國家/地區
    • 市場預測

第 10 章：SWOT 分析

  • 概述
  • 優勢
  • 弱點
  • 機會
  • 威脅

第 11 章：價值鏈分析

第 12 章：波特五力分析

  • 概述
  • 買家的議價能力
  • 供應商的議價能力
  • 競爭程度
  • 新進入者的威脅
  • 替代品的威脅

第 13 章：價格分析

第14章：競爭格局

  • 市場結構
  • 關鍵參與者
  • 關鍵參與者簡介
    • Abbott Laboratories
    • Alfa Scientific Designs Inc.
    • Bio-Rad Laboratories Inc.
    • Dragerwerk AG & Co. KGaA
    • Laboratory Corporation of America Holdings
    • Lifeloc Technologies Inc.
    • Omega Laboratories Inc.
    • OraSure Technologies Inc.
    • Psychemedics Corporation
    • Quest Diagnostics Incorporated
    • Siemens AG
    • Thermo Fisher Scientific Inc.
Product Code: SR112024A5624

The global drug screening market size reached US$ 6.4 Billion in 2023. Looking forward, IMARC Group expects the market to reach US$ 11.7 Billion by 2032, exhibiting a growth rate (CAGR) of 6.7% during 2024-2032. The growing number of drug traffickers and local dealers, rising cases of substance abuse, and increasing employment of virtual currencies represent some of the key factors driving the drug screening market growth.

Drug Screening Market Analysis:

Major Market Drivers: Increasing demand for drug screening as it is accurate and provides spontaneous results is primarily driving the growth of the market. Furthermore, the rising cases of substance abuse around the world are also propelling the global market.

Key Market Trends: The integration of advanced technologies such as automation, artificial intelligence (AI), and molecular diagnostics with drug screening tests to streamline workflows, reduce human errors, and enhance testing is acting as one of the significant key trends, bolstering the market growth.

Competitive Landscape: Some of the leading drug screening market companies include Abbott Laboratories, Alfa Scientific Designs Inc., Bio-Rad Laboratories Inc., Dragerwerk AG & Co. KGaA, Laboratory Corporation of America Holdings, Lifeloc Technologies Inc., Omega Laboratories Inc., OraSure Technologies Inc., Psychemedics Corporation, Quest Diagnostics Incorporated, Siemens AG, and Thermo Fisher Scientific Inc., among others.

Geographical Trends: According to the report, North America is the largest market for drug screening. The growth of the region can be attributed to the escalating cases of substance abuse, the increasing number of drug dealers, and the rising black marketing of prescribed drugs.

Challenges and Opportunities: The drug screening market faces hurdles related to the development of accurate and reliable tests, overcoming false positives and negatives, and addressing privacy and ethical concerns regarding sample collection and testing procedures. Opportunities lie in the integration of advanced technologies such as AI and machine learning for data analysis and the development of portable and point-of-care testing devices for convenient and rapid screening applications.

Drug Screening Market Trends:

Rise in Drug and Alcohol Consumption

The increasing consumption of drugs is resulting in an increased demand for drug-screening products. For instance, according to the 2023 European Drug Report, approximately 83.4 million adults (29%) in the European Union have reportedly used illicit drugs at least once. Cannabis is the predominant illicit drug consumed in Europe, with an estimated 8% of European adults using it in 2022, based on national surveys. Thus, a high number of the population consumes drugs, which impacts the lives of individuals and is likely to increase demand for drug screening, thereby bolstering the drug screening market's recent price. Additionally, the rising utilization of drugs and alcohol, along with the need for treatment, is anticipated to drive up the demand for drug screening in hospitals. For instance, as per National statistics published by GOV. UK, in December 2023, between April 2022 and March 2023, around 290,635 adults received support for substance use issues. This is a small rise compared to the previous year, around 289,215. Moreover, the same source stated that the number of adults entering treatment from 2022 to 2023 was approx. 137,749, which is higher than the previous two years' figures of 130,490 and 133,704. Such a significant rise in the number of people undergoing substance use is anticipated to propel the drug screening market demand.

Government Regulations

Several laws and regulations mandate drug and alcohol testing in various sectors, and the implementation of such laws is augmenting the demand for drug-screening products and devices. For instance, in November 2022, the Federal Motor Carrier Safety Administration (FMCSA) released updates outlining the drug and alcohol testing requirements. These regulations specify the individuals subject to testing, the frequency of testing, and the circumstances triggering testing. Additionally, the regulations safeguard employee privacy by limiting the use and disclosure of sensitive drug and alcohol testing information by employers and service agents. Besides the regulatory framework, government authorities of various nations are also taking initiatives to help severe addicts and individuals suffering from drug abuse, which is further propelling the drug screening market share. For instance, Nasha Mukt Bharat Abhiyaan is a program by the Indian Government that intends to reach out to the masses and spread awareness about substance abuse through various activities like awareness generation programs. Similarly, the government authorities of Canada are also investing in anti-drug strategy projects to help people with addiction come out of substance abuse. For example, the Calgary John Howard Society in Alberta, Canada, focuses on assisting youths aged 13 to 24 who face the risk of school dropout due to drug addiction.

Advancements in Testing Technologies

Ongoing advancements in drug screening technologies, such as rapid testing kits, laboratory-based assays, and point-of-care devices, are further driving the market growth by offering faster, more accurate, and cost-effective screening solutions. Moreover, the continuous improvement of drug screening technologies is resulting in enhanced accuracy and reliability and reduced likelihood of false positives or false negatives, ensuring confidence in test results and minimizing the need for confirmatory testing, thereby streamlining the screening process and reducing costs. For instance, in February 2024, Mobile Health introduced a new rapid drug testing service in New York clinics for employers to screen and hire candidates easily. Similarly, in October 2023, ProciseDx Inc. received de novo FDA clearance for the therapeutic drug monitoring (TDM) tests for adalimumab (Humira and biosimilar Amgevita) and infliximab (Remicade and biosimilars Inflectra and Renflexis). These assays, called Procise ADL and Procise IFX, are used to quantify adalimumab (ADL) and infliximab (IFX) in patients suffering from inflammatory bowel diseases (IBD) who are taking these drugs. Increasing approval of new drug tests and instruments is anticipated to propel the drug screening market revenue in the coming years.

Global Drug Screening Industry Segmentation:

IMARC Group provides an analysis of the key trends in each sub-segment of the global drug screening market report, along with forecasts at the global, regional, and country levels from 2024-2032. Our report has categorized the market based on product and service, sample type, and end user.

Breakup by Product and Service:

Equipment

Immunoassay Analyzers

Chromatography Instruments

Breath Analyzers

Rapid Testing Devices

Urine Testing Devices

Oral Fluid Testing Devices

Consumables

Assay Kits

Sample Collection Cups

Calibrators and Controls

Others

Laboratory Services

Rapid testing devices represented the largest segment

The drug screening market report has provided a detailed breakup and analysis of the drug screening market based on the product and service. This includes equipment (immunoassay analyzers, chromatography instruments, and breath analyzers); rapid testing devices (urine testing devices and oral fluid testing devices); consumables (assay kits, sample collection cups, calibrators and controls, and others); and laboratory services. According to the report, rapid testing devices (urine testing devices and oral fluid testing devices) represented the largest segment.

Rapid drug screening test devices are portable, easy-to-use tools designed for quick detection of drugs in various sample types, such as urine, saliva, or blood. These devices offer several benefits, including rapid results within minutes, enabling on-the-spot decision-making in scenarios like workplace testing or roadside screening. Their simplicity allows for minimal training requirements, making them accessible to a wide range of users. Moreover, rapid tests are cost-effective, reducing the need for laboratory analysis and turnaround time. For instance, Drager, a German company based in Lubeck that makes breathing and protection equipment, gas detection and analysis systems, and non-invasive patient monitoring technologies, introduced a rapid test named DrugTest 5000. In this test, saliva samples can be analyzed immediately for an accurate result on the spot. Furthermore, rapid screening devices play a crucial role in emergencies, aiding in the quick identification of drug intoxication or overdose for prompt medical intervention.

Breakup by Sample Type:

Urine Samples

Breath Samples

Oral Fluid Samples

Hair Samples

Others

Urine samples accounted for the largest market share

A detailed breakup and analysis of the drug screening market based on the sample type has also been provided in the report. This includes urine samples, breath samples, oral fluid samples, hair samples, and others. According to the report, urine samples accounted for the largest market share.

As per the drug screening market overview, urine sample drug testing offers several benefits, making it a preferred method over other sample types in many scenarios. Firstly, urine testing is non-invasive and relatively easy to collect, minimizing discomfort and ensuring employee cooperation. Secondly, urine samples can detect a wide range of drugs and their metabolites, providing comprehensive screening capabilities. Thirdly, urine testing is cost-effective and suitable for high-volume testing, making it practical for workplace screening programs. Furthermore, urine testing is capable of detecting recent drug use, making it suitable for detecting impairment in safety-sensitive industries. Lastly, this testing is less susceptible to adulteration or tampering compared to other sample types, ensuring the integrity and reliability of test results.

Breakup by End User:

Hospitals

Drug Testing Laboratories

Workplaces

Drug Treatment Centers

Pain Management Centers

Personal Users

Criminal Justice System and Law Enforcement Agencies

Workplaces accounted for the largest market share

A detailed breakup and analysis of the drug screening market based on the end user has also been provided in the report. This includes hospitals, drug testing laboratories, workplaces, drug treatment centers, pain management centers, personal users, and criminal justice system and law enforcement agencies. According to the report, workplaces accounted for the largest market share.

Drug screening tests in workplaces are conducted to detect the presence of drugs or alcohol in employees. These tests are typically performed as part of pre-employment screening, random testing, post-accident testing, or reasonable suspicion testing. The aim is to ensure a safe and productive work environment, minimize the risk of accidents and injuries, and deter substance abuse among employees.

Breakup by Region:

North America

United States

Canada

Asia-Pacific

China

Japan

India

South Korea

Australia

Indonesia

Others

Europe

Germany

France

United Kingdom

Italy

Spain

Russia

Others

Latin America

Brazil

Mexico

Others

Middle East and Africa

North America (the United States and Canada) was the largest market for drug screening

The report has also provided a comprehensive analysis of all the major regional markets, which include North America (the United States and Canada); Asia Pacific (China, Japan, India, South Korea, Australia, Indonesia, and others); Europe (Germany, France, the United Kingdom, Italy, Spain, Russia, and others); Latin America (Brazil, Mexico, and others); and the Middle East and Africa. According to the report, North America (the United States and Canada) was the largest market for drug screening.

Some of the factors driving the North America drug screening market included the growing cases of substance abuse, the increasing number of drug dealers, and the rising black marketing of prescribed drugs. Moreover, drug screening market statistics by IMARC indicate that the growing substance abuse rates in the region are bolstering the need for drug screening. For instance, in February 2023, according to an article published by the Pennsylvania State University, around 63% of adults aged 18 years and above were reported to alcohol consumption in the United States in 2022. Among these, males (66%) had higher alcohol consumption as compared to females (61%). Thus, the large number of alcohol consumers raises the need for drug-testing products and services and is augmenting the market growth in North America. Moreover, the government authorities of North America are mandating drug screening tests in various sectors, which is further catalyzing the market growth. For instance, in May 2023, the United States Department of Transportation regulated the drug testing program by including oral fluid testing to improve safety and reduce the chances of cheating involved with urine drug tests.

Competitive Landscape:

The report has also provided a comprehensive analysis of the competitive landscape in the global drug screening market. Competitive analysis such as market structure, market share by key players, player positioning, top winning strategies, competitive dashboard, and company evaluation quadrant has been covered in the report. Also, detailed profiles of all major companies have been provided. Some of the companies covered include:

Abbott Laboratories

Alfa Scientific Designs Inc.

Bio-Rad Laboratories Inc.

Dragerwerk AG & Co. KGaA

Laboratory Corporation of America Holdings

Lifeloc Technologies Inc.

Omega Laboratories Inc.

OraSure Technologies Inc.

Psychemedics Corporation

Quest Diagnostics Incorporated

Siemens AG

Thermo Fisher Scientific Inc.

(Kindly note that this only represents a partial list of companies, and the complete list has been provided in the report.)

Drug Screening Market Recent Developments:

March 2024: bioXcelerate, a new and innovative health data science division of Optima Partners Limited, revealed a groundbreaking AI tool, which is set to accelerate the process of identifying and developing new drugs. The tool, known as PleioGraph, can analyze complex medical data 100 times faster than existing state-of-the-art methods used to detect biological networks that explain disease risk and inform drug discovery.

December 2023: Quest Diagnostics, one of the leading providers of diagnostic information services, unveiled its new confirmatory testing service for novel psychoactive substances (NPS). The new panel, which tests for 88 compounds, covers a broad array of drug classes, such as designer opioids, designer benzodiazepines, designer stimulants, fentanyl analogs, synthetic cannabinoids, and other illicit additives.

October 2023: In India, Kerala police launched a rapid drug screening system that involves the utilization of a hand-held device, named the SoToxa Mobile Test System, and detects drug usage in 5 minutes.

Key Questions Answered in This Report

  • 1. What was the size of the global drug screening market in 2023?
  • 2. What is the expected growth rate of the global drug screening market during 2024-2032?
  • 3. What are the key factors driving the global drug screening market?
  • 4. What has been the impact of COVID-19 on the global drug screening market?
  • 5. What is the breakup of the global drug screening market based on the product and service?
  • 6. What is the breakup of the global drug screening market based on the sample type?
  • 7. What is the breakup of the global drug screening market based on the end user?
  • 8. What are the key regions in the global drug screening market?
  • 9. Who are the key players/companies in the global drug screening market?

Table of Contents

1 Preface

2 Scope and Methodology

  • 2.1 Objectives of the Study
  • 2.2 Stakeholders
  • 2.3 Data Sources
    • 2.3.1 Primary Sources
    • 2.3.2 Secondary Sources
  • 2.4 Market Estimation
    • 2.4.1 Bottom-Up Approach
    • 2.4.2 Top-Down Approach
  • 2.5 Forecasting Methodology

3 Executive Summary

4 Introduction

  • 4.1 Overview
  • 4.2 Key Industry Trends

5 Global Drug Screening Market

  • 5.1 Market Overview
  • 5.2 Market Performance
  • 5.3 Impact of COVID-19
  • 5.4 Market Forecast

6 Market Breakup by Product and Service

  • 6.1 Equipment
    • 6.1.1 Market Trends
    • 6.1.2 Key Segments
      • 6.1.2.1 Immunoassay Analyzers
      • 6.1.2.2 Chromatography Instruments
      • 6.1.2.3 Breath Analyzers
    • 6.1.3 Market Forecast
  • 6.2 Rapid Testing Devices
    • 6.2.1 Market Trends
    • 6.2.2 Key Segments
      • 6.2.2.1 Urine Testing Devices
      • 6.2.2.2 Oral Fluid Testing Devices
    • 6.2.3 Market Forecast
  • 6.3 Consumables
    • 6.3.1 Market Trends
    • 6.3.2 Key Segments
      • 6.3.2.1 Assay Kits
      • 6.3.2.2 Sample Collection Cups
      • 6.3.2.3 Calibrators and Controls
      • 6.3.2.4 Others
    • 6.3.3 Market Forecast
  • 6.4 Laboratory Services
    • 6.4.1 Market Trends
    • 6.4.2 Market Forecast

7 Market Breakup by Sample Type

  • 7.1 Urine Samples
    • 7.1.1 Market Trends
    • 7.1.2 Market Forecast
  • 7.2 Breath Samples
    • 7.2.1 Market Trends
    • 7.2.2 Market Forecast
  • 7.3 Oral Fluid Samples
    • 7.3.1 Market Trends
    • 7.3.2 Market Forecast
  • 7.4 Hair Samples
    • 7.4.1 Market Trends
    • 7.4.2 Market Forecast
  • 7.5 Others
    • 7.5.1 Market Trends
    • 7.5.2 Market Forecast

8 Market Breakup by End User

  • 8.1 Hospitals
    • 8.1.1 Market Trends
    • 8.1.2 Market Forecast
  • 8.2 Drug Testing Laboratories
    • 8.2.1 Market Trends
    • 8.2.2 Market Forecast
  • 8.3 Workplaces
    • 8.3.1 Market Trends
    • 8.3.2 Market Forecast
  • 8.4 Drug Treatment Centers
    • 8.4.1 Market Trends
    • 8.4.2 Market Forecast
  • 8.5 Pain Management Centers
    • 8.5.1 Market Trends
    • 8.5.2 Market Forecast
  • 8.6 Personal Users
    • 8.6.1 Market Trends
    • 8.6.2 Market Forecast
  • 8.7 Criminal Justice System and Law Enforcement Agencies
    • 8.7.1 Market Trends
    • 8.7.2 Market Forecast

9 Market Breakup by Region

  • 9.1 North America
    • 9.1.1 United States
      • 9.1.1.1 Market Trends
      • 9.1.1.2 Market Forecast
    • 9.1.2 Canada
      • 9.1.2.1 Market Trends
      • 9.1.2.2 Market Forecast
  • 9.2 Asia-Pacific
    • 9.2.1 China
      • 9.2.1.1 Market Trends
      • 9.2.1.2 Market Forecast
    • 9.2.2 Japan
      • 9.2.2.1 Market Trends
      • 9.2.2.2 Market Forecast
    • 9.2.3 India
      • 9.2.3.1 Market Trends
      • 9.2.3.2 Market Forecast
    • 9.2.4 South Korea
      • 9.2.4.1 Market Trends
      • 9.2.4.2 Market Forecast
    • 9.2.5 Australia
      • 9.2.5.1 Market Trends
      • 9.2.5.2 Market Forecast
    • 9.2.6 Indonesia
      • 9.2.6.1 Market Trends
      • 9.2.6.2 Market Forecast
    • 9.2.7 Others
      • 9.2.7.1 Market Trends
      • 9.2.7.2 Market Forecast
  • 9.3 Europe
    • 9.3.1 Germany
      • 9.3.1.1 Market Trends
      • 9.3.1.2 Market Forecast
    • 9.3.2 France
      • 9.3.2.1 Market Trends
      • 9.3.2.2 Market Forecast
    • 9.3.3 United Kingdom
      • 9.3.3.1 Market Trends
      • 9.3.3.2 Market Forecast
    • 9.3.4 Italy
      • 9.3.4.1 Market Trends
      • 9.3.4.2 Market Forecast
    • 9.3.5 Spain
      • 9.3.5.1 Market Trends
      • 9.3.5.2 Market Forecast
    • 9.3.6 Russia
      • 9.3.6.1 Market Trends
      • 9.3.6.2 Market Forecast
    • 9.3.7 Others
      • 9.3.7.1 Market Trends
      • 9.3.7.2 Market Forecast
  • 9.4 Latin America
    • 9.4.1 Brazil
      • 9.4.1.1 Market Trends
      • 9.4.1.2 Market Forecast
    • 9.4.2 Mexico
      • 9.4.2.1 Market Trends
      • 9.4.2.2 Market Forecast
    • 9.4.3 Others
      • 9.4.3.1 Market Trends
      • 9.4.3.2 Market Forecast
  • 9.5 Middle East and Africa
    • 9.5.1 Market Trends
    • 9.5.2 Market Breakup by Country
    • 9.5.3 Market Forecast

10 SWOT Analysis

  • 10.1 Overview
  • 10.2 Strengths
  • 10.3 Weaknesses
  • 10.4 Opportunities
  • 10.5 Threats

11 Value Chain Analysis

12 Porters Five Forces Analysis

  • 12.1 Overview
  • 12.2 Bargaining Power of Buyers
  • 12.3 Bargaining Power of Suppliers
  • 12.4 Degree of Competition
  • 12.5 Threat of New Entrants
  • 12.6 Threat of Substitutes

13 Price Analysis

14 Competitive Landscape

  • 14.1 Market Structure
  • 14.2 Key Players
  • 14.3 Profiles of Key Players
    • 14.3.1 Abbott Laboratories
      • 14.3.1.1 Company Overview
      • 14.3.1.2 Product Portfolio
      • 14.3.1.3 Financials
      • 14.3.1.4 SWOT Analysis
    • 14.3.2 Alfa Scientific Designs Inc.
      • 14.3.2.1 Company Overview
      • 14.3.2.2 Product Portfolio
    • 14.3.3 Bio-Rad Laboratories Inc.
      • 14.3.3.1 Company Overview
      • 14.3.3.2 Product Portfolio
      • 14.3.3.3 Financials
      • 14.3.3.4 SWOT Analysis
    • 14.3.4 Dragerwerk AG & Co. KGaA
      • 14.3.4.1 Company Overview
      • 14.3.4.2 Product Portfolio
      • 14.3.4.3 Financials
      • 14.3.4.4 SWOT Analysis
    • 14.3.5 Laboratory Corporation of America Holdings
      • 14.3.5.1 Company Overview
      • 14.3.5.2 Product Portfolio
      • 14.3.5.3 Financials
    • 14.3.6 Lifeloc Technologies Inc.
      • 14.3.6.1 Company Overview
      • 14.3.6.2 Product Portfolio
      • 14.3.6.3 Financials
    • 14.3.7 Omega Laboratories Inc.
      • 14.3.7.1 Company Overview
      • 14.3.7.2 Product Portfolio
    • 14.3.8 OraSure Technologies Inc.
      • 14.3.8.1 Company Overview
      • 14.3.8.2 Product Portfolio
      • 14.3.8.3 Financials
      • 14.3.8.4 SWOT Analysis
    • 14.3.9 Psychemedics Corporation
      • 14.3.9.1 Company Overview
      • 14.3.9.2 Product Portfolio
      • 14.3.9.3 Financials
    • 14.3.10 Quest Diagnostics Incorporated
      • 14.3.10.1 Company Overview
      • 14.3.10.2 Product Portfolio
      • 14.3.10.3 Financials
    • 14.3.11 Siemens AG
      • 14.3.11.1 Company Overview
      • 14.3.11.2 Product Portfolio
      • 14.3.11.3 Financials
      • 14.3.11.4 SWOT Analysis
    • 14.3.12 Thermo Fisher Scientific Inc.
      • 14.3.12.1 Company Overview
      • 14.3.12.2 Product Portfolio
      • 14.3.12.3 Financials
      • 14.3.12.4 SWOT Analysis

List of Figures

  • Figure 1: Global: Drug Screening Market: Major Drivers and Challenges
  • Figure 2: Global: Drug Screening Market: Sales Value (in Billion US$), 2018-2023
  • Figure 3: Global: Drug Screening Market Forecast: Sales Value (in Billion US$), 2024-2032
  • Figure 4: Global: Drug Screening Market: Breakup by Product and Service (in %), 2023
  • Figure 5: Global: Drug Screening Market: Breakup by Sample Type (in %), 2023
  • Figure 6: Global: Drug Screening Market: Breakup by End User (in %), 2023
  • Figure 7: Global: Drug Screening Market: Breakup by Region (in %), 2023
  • Figure 8: Global: Drug Screening (Equipment) Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 9: Global: Drug Screening (Equipment) Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 10: Global: Drug Screening (Rapid Testing Devices) Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 11: Global: Drug Screening (Rapid Testing Devices) Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 12: Global: Drug Screening (Consumables) Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 13: Global: Drug Screening (Consumables) Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 14: Global: Drug Screening (Laboratory Services) Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 15: Global: Drug Screening (Laboratory Services) Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 16: Global: Drug Screening (Urine Samples) Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 17: Global: Drug Screening (Urine Samples) Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 18: Global: Drug Screening (Breath Samples) Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 19: Global: Drug Screening (Breath Samples) Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 20: Global: Drug Screening (Oral Fluid Samples) Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 21: Global: Drug Screening (Oral Fluid Samples) Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 22: Global: Drug Screening (Hair Samples) Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 23: Global: Drug Screening (Hair Samples) Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 24: Global: Drug Screening (Other Sample Types) Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 25: Global: Drug Screening (Other Sample Types) Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 26: Global: Drug Screening (Hospitals) Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 27: Global: Drug Screening (Hospitals) Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 28: Global: Drug Screening (Drug Testing Laboratories) Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 29: Global: Drug Screening (Drug Testing Laboratories) Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 30: Global: Drug Screening (Workplaces) Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 31: Global: Drug Screening (Workplaces) Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 32: Global: Drug Screening (Drug Treatment Centers) Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 33: Global: Drug Screening (Drug Treatment Centers) Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 34: Global: Drug Screening (Pain Management Centers) Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 35: Global: Drug Screening (Pain Management Centers) Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 36: Global: Drug Screening (Personal Users) Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 37: Global: Drug Screening (Personal Users) Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 38: Global: Drug Screening (Criminal Justice System and Law Enforcement Agencies) Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 39: Global: Drug Screening (Criminal Justice System and Law Enforcement Agencies) Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 40: North America: Drug Screening Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 41: North America: Drug Screening Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 42: United States: Drug Screening Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 43: United States: Drug Screening Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 44: Canada: Drug Screening Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 45: Canada: Drug Screening Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 46: Asia-Pacific: Drug Screening Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 47: Asia-Pacific: Drug Screening Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 48: China: Drug Screening Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 49: China: Drug Screening Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 50: Japan: Drug Screening Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 51: Japan: Drug Screening Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 52: India: Drug Screening Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 53: India: Drug Screening Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 54: South Korea: Drug Screening Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 55: South Korea: Drug Screening Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 56: Australia: Drug Screening Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 57: Australia: Drug Screening Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 58: Indonesia: Drug Screening Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 59: Indonesia: Drug Screening Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 60: Others: Drug Screening Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 61: Others: Drug Screening Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 62: Europe: Drug Screening Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 63: Europe: Drug Screening Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 64: Germany: Drug Screening Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 65: Germany: Drug Screening Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 66: France: Drug Screening Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 67: France: Drug Screening Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 68: United Kingdom: Drug Screening Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 69: United Kingdom: Drug Screening Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 70: Italy: Drug Screening Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 71: Italy: Drug Screening Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 72: Spain: Drug Screening Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 73: Spain: Drug Screening Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 74: Russia: Drug Screening Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 75: Russia: Drug Screening Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 76: Others: Drug Screening Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 77: Others: Drug Screening Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 78: Latin America: Drug Screening Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 79: Latin America: Drug Screening Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 80: Brazil: Drug Screening Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 81: Brazil: Drug Screening Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 82: Mexico: Drug Screening Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 83: Mexico: Drug Screening Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 84: Others: Drug Screening Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 85: Others: Drug Screening Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 86: Middle East and Africa: Drug Screening Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 87: Middle East and Africa: Drug Screening Market: Breakup by Country (in %), 2023
  • Figure 88: Middle East and Africa: Drug Screening Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 89: Global: Drug Screening Industry: SWOT Analysis
  • Figure 90: Global: Drug Screening Industry: Value Chain Analysis
  • Figure 91: Global: Drug Screening Industry: Porter's Five Forces Analysis

List of Tables

  • Table 1: Global: Drug Screening Market: Key Industry Highlights, 2023 and 2032
  • Table 2: Global: Drug Screening Market Forecast: Breakup by Product and Service (in Million US$), 2024-2032
  • Table 3: Global: Drug Screening Market Forecast: Breakup by Sample Type (in Million US$), 2024-2032
  • Table 4: Global: Drug Screening Market Forecast: Breakup by End User (in Million US$), 2024-2032
  • Table 5: Global: Drug Screening Market Forecast: Breakup by Region (in Million US$), 2024-2032
  • Table 6: Global: Drug Screening Market: Competitive Structure
  • Table 7: Global: Drug Screening Market: Key Players